According to Scholar Rock Holding's latest financial reports the company has $0.27 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.31 B | 24.65% |
2021-12-31 | $0.25 B | -25.81% |
2020-12-31 | $0.34 B | 116.6% |
2019-12-31 | $0.15 B | -10.36% |
2018-12-31 | $0.17 B | 203.05% |
2017-12-31 | $57.95 M | 106.74% |
2016-12-31 | $28.03 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $5.29 M | -98.11% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.12 B | -55.20% | ๐ฌ๐ง UK |
Novavax NVAX | $0.56 B | 103.08% | ๐บ๐ธ USA |
Novocure
NVCR | $0.91 B | 225.29% | Jersey |